Skip to main content
Access
Home Alt+0
Navigation Alt+1
Content Alt+2
Language
عربي
中文
English
Français
Русский
Español
Navigation
Home
Health topics
Data and statistics
Media centre
Publications
Countries
Programmes and projects
About
WHO
Search
Search the
WHO
.int site
Submit
Advanced search
Medicines
Subnavigation
Medicines
About us
News and events
Areas of work
Medicines publications
Medicines topics
Training resources
Useful links
Transparency International
Corruption and health
Global Corruption Report 2007
The World Bank
Anti-corruption strategy
Governance group of the World Bank Institute
U4 - Utstein Anti-Corruption Resource Centre
Corruption in the health sector
Corruption glossary
United Nations Office on Drugs and Crime
UNODC and corruption
United Nations Development Programme
Democratic Governance
Organisation for Economic Co-operation and Development (OECD)
Corruption programme
Anti-Bribery Convention
Medicines Transparency Alliance, MeTA
Medicines Transparency Alliance
Good Governance for Medicines
Why is good governance relevant to the pharmaceutical public sector?
Goal and specific objectives
Implementation of the programme
Country progress to date and future development
Related documents
Partners
Past events
Share
Email
Twitter
Facebook
Google
Delicious
LinkedIn
More...
Print
You are here:
Medicines
Areas of work
Medicines policy